Malignant neoplasm of other and unspecified urinary organs Clinical Trials

13 clinical trials for Malignant neoplasm of other and unspecified urinary organs across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Non-interventional, prospective study to evaluate the predictive potential of early CRP kinetics, in particular the CRP flare-response phenomenon, on the efficacy of immunotherapy in advanced urooncological tumors (renal cell carcinoma, urothelial carcinoma). "Prospective Evaluation of the CRP-FLAre phenomenon on Immunotherapy REsponse in Urooncology (FLAIRE)." — RECRUITING
• GUARDIANS-Registry (GenitoUrinary Academic Research Development Initiative and Network) — RECRUITING
• Improvement of the quality of care through standardized documentation — RECRUITING
• Atypical cells in urine - Validation of a new tumormarker in urothelial carcinoma (AG ACU) — RECRUITING
• National urothelial carcinoma registry for recording and improving the quality of care across sectors — RECRUITING
• Value of FGFR alterations on treatment outcomes in bladder cancer: a multicenter collaboration project — RECRUITING
• Prospective validation of membranous NECTIN-4 expression as biomarker to predict enfortumab vedotin + pembrolizumab response in metastatic urothelial cancer — OTHER
• Comparison of Cystectomy and Nephroureterectomy with Alternative Therapeutic Strategies in Patients with Urothelial Carcinoma of the Urinary Bladder and Upper Urinary Tract – Analysis of Clinicopathological Factors and Survival Data. — NOT_YET_RECRUITING
• FGFR3-TRACE (Tracking Mutations and Fusions in Urothelial Cancer): Use of anonymized patient samples for the establishment of newly developed assays for the detection of diagnostically relevant cancer biomarkers. — NOT_YET_RECRUITING
• Use and acceptance of a psycho-oncological online help for urogenital cancers — OTHER
• Propagation of organoids from urology tumors — NOT_YET_RECRUITING
• Observational longitudinal trial of metastatic urothelial cancer patients to evaluate blood-based miRNA profiles (miRisk score) for treatment prognosis and efficacy prediction to immunotherapy — NOT_YET_RECRUITING
• Patient empowerment and risk–assessment to improve outcome in the elderly after gastrointestinal, thoracic or urogenital cancer surgery - Pilot study — OTHER

Refine this search